ArticleFrontiers in endocrinology2022

DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells.

Federica Mangili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.